ImmunoGen shares owned by Birchview Capital
Quarter-by-quarter ownership of ImmunoGen shares owned by Birchview Capital
from 13F filings
Historical chart of Birchview Capital investment in ImmunoGen
Tip: Access up to 7 years of quarterly data
All positions including ImmunoGen held by Birchview Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in ImmunoGen by Birchview Capital
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-09-30 | $3.0M | 190k | 15.87 |
2023-06-30 | $3.6M | 190k | 18.87 |
2023-03-31 | $576k | 150k | 3.84 |
2022-12-31 | $744k | 150k | 4.96 |
2022-09-30 | $717k | 150k | 4.78 |
2022-06-30 | $675k | 150k | 4.50 |
2022-03-31 | $904k | 190k | 4.76 |
2021-12-31 | $1.4M | 190k | 7.42 |
2021-09-30 | $1.1M | 190k | 5.67 |
2021-06-30 | $1.3M | 190k | 6.59 |
2021-03-31 | $1.5M | 190k | 8.10 |
2020-12-31 | $1.2M | 190k | 6.45 |
2020-09-30 | $684k | 190k | 3.60 |
2020-06-30 | $874k | 190k | 4.60 |
2020-03-31 | $648k | 190k | 3.41 |
2019-12-31 | $920k | 180k | 5.11 |
2019-09-30 | $436k | 180k | 2.42 |
2019-06-30 | $391k | 180k | 2.17 |
2019-03-31 | $244k | 90k | 2.71 |
2018-12-31 | $106k | 22k | 4.82 |